An Orally Bioavailable and Highly Efficacious Inhibitor of CDK9/FLT3 for the Treatment of Acute Myeloid Leukemia.
Anshabo AT, Bantie L, Diab S, Lenjisa J, Kebede A, Long Y, Heinemann G, Karanjia J, Noll B, Basnet SKC, Li M, Milne R, Albrecht H, Wang S.
Anshabo AT, et al. Among authors: albrecht h.
Cancers (Basel). 2022 Feb 22;14(5):1113. doi: 10.3390/cancers14051113.
Cancers (Basel). 2022.
PMID: 35267421
Free PMC article.